Literature DB >> 26174987

Mesothelioma cells breaking bad: loss of integrin α7 promotes cell motility and poor clinical outcomes in patients.

Dean J Burkin1, Tatiana M Fontelonga1.   

Abstract

Mesothelioma is a disease of pleural cells lining the lungs which is often caused by exposure to asbestos. The molecular mechanism(s) that regulate the transformation of pleural mesothelioma cells to a migratory and malignant phenotype are unclear. In recent work published in this journal, Laszlo et al performed a set of elegant experiments to identify a key molecular mechanism that may explain the aggressive nature of this disease. Using patient-derived mesothelioma cells with high versus low migratory activity, the authors conducted a genome-wide expression analysis. They identified a significant reduction in ITGA7 expression only in highly migratory malignant pleural mesothelioma cells and showed that loss of ITGA7 expression was associated with methylation of the promoter. Forced expression of integrin α7 reversed the migratory phenotype of these cells. Finally, the authors identified a strong correlation between ITGA7 expression and patient survival. Together, these results identify expression of integrin α7 as a molecular mechanism for the aggressive migratory transformation of mesothelioma and identify a potentially novel diagnostic and therapeutic target.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  epigenetics; integrin α7; malignancy; mesothelioma

Mesh:

Substances:

Year:  2015        PMID: 26174987     DOI: 10.1002/path.4587

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Integrin α7: a novel promising target in glioblastoma stem cells.

Authors:  Estefania Carrasco-Garcia; Jaione Auzmendi-Iriarte; Ander Matheu
Journal:  Stem Cell Investig       Date:  2018-01-13

Review 2.  Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.

Authors:  Ashleigh Parkin; Jennifer Man; Paul Timpson; Marina Pajic
Journal:  FEBS J       Date:  2019-08-05       Impact factor: 5.542

3.  Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma.

Authors:  Nobuhiko Kobayashi; Tsukasa Oda; Makiko Takizawa; Takuma Ishizaki; Norifumi Tsukamoto; Akihiko Yokohama; Hisashi Takei; Takayuki Saitoh; Hiroaki Shimizu; Kazuki Honma; Kei Kimura-Masuda; Yuko Kuroda; Rei Ishihara; Yuki Murakami; Hirokazu Murakami; Hiroshi Handa
Journal:  Cancers (Basel)       Date:  2020-02-05       Impact factor: 6.639

4.  Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer.

Authors:  Dongping Xia; Beibei Chen; Xun Yang
Journal:  J Clin Lab Anal       Date:  2019-08-16       Impact factor: 2.352

5.  Integrin α7 knockdown suppresses cell proliferation, migration, invasion and EMT in hepatocellular carcinoma.

Authors:  Zhiyong Wu; Xiaoyu Kong; Zhihui Wang
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

6.  Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma in vitro.

Authors:  Tobias Engl; Jochen Rutz; Sebastian Maxeiner; Sorel Fanguen; Eva Juengel; Sebastian Koschade; Frederik Roos; Wael Khoder; Igor Tsaur; Roman A Blaheta
Journal:  Oncotarget       Date:  2018-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.